Introduction
99m Tc-Duramycin is a peptide-based molecular probe that binds specifically to phosphatidylethanolamine (PE). The goal was to characterize the kinetics of molecular interactions between 99m Tc-Duramycin and the target tissue.
Methods
High level of accessible PE is induced in cardiac tissues by myocardial ischemia (30 min) and reperfusion (120 min) in Sprague Dawley rats. Target binding and biodistribution of 99m Tc-duramycin was captured using SPECT/CT. To quantify the binding kinetics, the presence of radioactivity in ischemic versus normal cardiac tissues was measured by gamma counting at 3, 10, 20, 60 and 180 min after injection. A partially inactivated form of 99m TcDuramycin was analyzed in the same fashion. A compartment model was developed to quantify the uptake kinetics of 99m Tc-Duramycin in normal and ischemic myocardial tissue.
INTRODUCTION
The asymmetrical distribution of phospholipids in cellular membranes is of fundamental importance [1, 2] . The status of this asymmetry has been increasingly recognized as a molecular marker for normality and diseases.
A number of imaging agents have been described in pursuit of targeted imaging capabilities for membrane phospholipids. Annexin V, the C2A domain of Synaptotagmin I, and the C2 domain of Lactadherin are examples of protein-based phosphatidylserine (PS)-binding imaging agents [3] [4] [5] . Structural features of these agents can be generalized as including 1) a binding site designed to accommodate the head group of a target phospholipid, and 2) exposed hydrophobic side chains at the vicinity of the binding site for interacting with the core of the phospholipid bilayer. The first feature enables the recognition of phospholipid head groups, while the second provides an anchoring mechanism that drives toward membrane binding.
Duramycin, which is a lantibiotic peptide, also meets the structural criteria for targeting phospholipid membranes, but it binds specifically to phosphatidylethanolamine (PE) [6] . Apart from been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.
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apoptosis, emerging evidence indicates that the dynamics of membrane PE is involved in a number of biological functions, including cytokinesis and possibly hemostasis [7, 8] . Thus, the unique binding activity of Duramycin adds to the repertoire of membrane-binding agents by enabling a new perspective in investigating the fundamental biology of membrane phospholipid distribution. Initial studies on 99m Tclabeled Duramycin indicate that the agent has good uptake in target tissues with rapid renal clearance and a low general background in vivo [9] . These properties are consistent with the structural features of Duramycin. More specifically, Duramycin is one of the smallest possible polypeptide (19 amino acids) that has a defined 3-dimensional binding structure [6, 10] . The peptide is extensively crosslinked by intramolecular covalent bridges, thus exhibiting relatively high in vivo stability. The agent has binding activities comparable to large proteins, yet with peptide-like pharmacokinetics. The combination of these factors makes Duramycin an attractive candidate as an imaging agent for studying phospholipid distribution in the living system.
In light of these initial findings, the objective of the current study was to understand how TcDuramycin and its molecular targets in vivo. We hypothesize that the combination of high target density and fast probe diffusion in tissue will lead to more efficient uptake, thus superior imaging properties.
The in vivo experiment will be carried using a rat model of myocardial ischemia and reperfusion. It has been demonstrated that both PE and PS are externalized in dead and dying mammalian cells [11] . Additionally, extensive pathological data have documented that prolonged ischemia followed by reperfusion causes destabilization of sarcolemmal structure. Severe ischemic insult eventually leads to compromised phospholipid membrane integrity, rendering high levels of phosphatidylethanolamine accessible to extracellular agents [12] [13] [14] . The advantages of using this animal model include a relatively defined perfusion profile, high target density in the ischemically damaged myocardium versus a low background in the viable myocardium. The quantitative dynamic data acquired using this system, in turn, will help better define the utilities of Tc-Duramycin as a novel radiopharmaceutical. Importantly, this type of data will be been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.
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instrumental in gauging the incremental values of an imaging agent compared with past and future generation agents for similar purposes.
MATERIALS AND METHODS

Radiolabeling of Duramycin
Duramycin and its partially inactivated form, Duramycin I , were covalently modified with HYNIC. The molecular weight of the HYNICmodified Duramycin was confirmed using Matrix-assisted laser desorption/ionization (MALDI) mass spectrometry. The radiopharmaceutical was prepared using a single-step kit formulation. The partially inactivated form of 99m Tc-Duramycin was prepared in the same fashion. Quality control steps, including stability tests, were carried out as described before [11] . The radiopharmaceutical dose consistently has a radiochemical purity at 95% or greater, and is stable without significant presence of dissociated radioactivity.
Rat Model of Myocardial Ischemia and Reperfusion
The animal protocol was approved by the Institutional Animal Care and Use Committee under the NIH guideline. Male SpragueDawley rats were anesthetized with sodium pentobarbital (50 mg/kg) intraperitoneally. After tracheal intubation, respiration was maintained using a rodent ventilator. An incision was made between the 4 th intercostal space to expose the heart. After opening the pericardium, the proximal left anterior descending coronary artery (LAD) was occluded for 30 minutes using a 6.0 suture at about 1 mm below the left atrial appendage. For sham operation, the suture was passed underneath the LAD without ligation. The presence of acute ischemia/reperfusion was confirmed by the pale appearance in the area-at-risk region and changes in ECG profiles. After reperfusion the chest wall was closed and ventilation was maintained until the rat could regain spontaneous respiration. The loose suture was left in place for area-at-risk staining.
SPECT studies
Static SPECT data were acquired at 40 min after radiotracer injection (37 MBq, i.v.) on a Triumph microSPECT/microCT scanner been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.
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(GE Healthcare, Waukesha, WI) equipped with a quad-detector SPECT system. The imaging parameters include multi-pinhole collimators for rat, 1.0 mm spatial resolution, 1100 counts per MBq sensitivity, 15% energy window centering at 140 keV, 50 × 50 mm trans-axial field of view, 170 mm axial field of view, 72 projections at 10 seconds each. SPECT acquisition was followed by CT, using the same field of view. The imaging data were reconstructed using the inbuilt software.
Spatial and Temporal uptake of 99m
Tc-Duramycin and its partially inactivated form in the area-at-risk
To investigate the temporal uptake kinetics of 99m Tc-Duramycin in the area-at-risk, 20 rats were enrolled to simulate acute myocardial infarction with 30 min coronary occlusion as described above. At 2 hr after reperfusion the radiotracer was injected intravenously (0.1 mCi). One group of 4 rats was sacrificed for measurements at each of the following time points: 3, 10, 20, 60 and 180 min after injection. Immediately before sacrifice, a second thoracotomy was performed to expose the heart. The LAD was re-occluded at the same location by tightening the suture in place. Two mls of Evans Blue dye (2% w/v in PBS, pH 7.4) was infused into the tail vein. Area-at-risk was delineated by an absence of blue dye uptake, while the normally perfused myocardium is stained dark blue. The heart was quickly excised, and the dissected tissues were separately weighed and collected in sample tubes for gamma counting as follows: normal (blue), ischemic infarct (unstained). Three aliquots of 99m Tc-Duramycin solution were taken at 5 ml each and were measured for radioactivity as standards for the calculation of total injected dosage (ID). The radioactivity uptake of 99m Tc-Duramycin at each time point after injection was presented as percentage of injected dosage per gram (%ID/g) with standard deviation. The above studies were repeated in another group of 20 rats using the partially inactivated form of Duramycin.
Compartmental model
We modified a previously developed compartmental model for quantitative interpretation of the uptake kinetics of active and partially inactivated 9m Tc-Duramycin in normal and infarct myocardium [17] . The model (Figure 1 ) consists a vascular region with volume V1 (ml) been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier. [C1](t) is the probe concentration in the MI vascular region at time t; C2(t) is the amount of bound probe at time t. B is the amount of free receptors or binding sites at time t that is readily accessible for probe within the MI blood region; ks is the probe-receptor association rate constant; F is the blood flow of the coronary circulation and [Cin](t) is the input probe concentration for the coronary circulation.
Using mass balance and mass action, the temporal variations in the activities of free and bound 99m Tc-Duramycin in V1 are described by Equations (1-2) been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier. TcDuramycin in normal myocardium reduce to Equation (1) with Bmax set to zero. Thus, for normal myocardium, Equation (3) reduces to: been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.
9
Statistical comparisons were carried out using t-test or paired ttest, with P < 0.05 as the criterion for statistical significance.
RESULTS
Whole-body imaging
Whole-body SPECT images are shown in Figure 2 . The high focal uptake of radioactivity is clearly seen in the ischemic myocardium in the tomographic images, which is made more conspicuous because of a lack of significant hepatic background. This is accompanied with a low systemic background and rapid renal/urinary clearance. 
Spatial and Temporal uptake of 99m
Tc-Duramycin in the area-at-risk
The uptake kinetics of 99m Tc-Duramycin in the area-at-risk was characterized by measuring the level of radioactivity at different time points after injection and is summarized in Figure 3 . Quantitative uptake data from dissected heart tissues of the infarct, and normal myocardium at 3, 10, 20, 60 and 180 min after tracer injection are presented. After injection the radioactivity uptake in the infarcted myocardium rapidly rose to 1.66 ± 1.18 (SD) %ID/g within 3 min, and approached a plateau by 10 min at 3.66 ± 0.76 %ID/g. The radioactivity uptake in the normal myocardium was low, reflecting the residual blood pool signal. According to the measurements using dissected heart tissues, at 60 min after injection, the average infarctto-normal ratio was ~29. The radiotracer was sequestered in the irreversibly damaged myocardium, which is consistent with the high binding affinity and specificity of Duramycin-PE interactions. Chemical modification of a single amino acid (D15) resulted in a marked reduction in probe uptake (Figure 3) . # Uptake of partially inactivated 99m Tc-Duramycin in area-at-risk is significantly different from its uptake in viable tissue at the same time (P < 0.05)
Kinetic analysis
The model parameters are V1 (ml), the volume of the vascular region; Bmax (nmol) the total amount of specific receptors or binding sites accessible to 99m Tc-Duramycin in MI tissue; and ks (ml nmol −1 min −1 ), the probe-receptor association rate constant. Estimation of these parameters was carried out as follows. First, Cb(t), as %ID, was determined by fitting Equation (5) Knowing Cb(t), the input probe concentration for the coronary circulation, [Cin](t) (in µM), was determined using where Vin (ml) is the rat blood volume (~ 7% of total body weight).
Knowing [Cin](t), V1 (ml) was estimated by solving Equation (1) with Bmax = 0, and fitting Equation (4) to active or partially inactivated 99m Tc-Duramycin activity versus time uptake data in normal myocardium (Figure 1) . The estimated values of V1 from the active or partially inactivated 99m Tc-Duramycin uptake data were virtually the same (Table 1) . Knowing V1, the remaining parameters namely, Bmax, and the association rate constant (ks) for the active (ksa ) and partially inactivated (ksi) 99m Tc-Duramycin were then estimated by solving Equations (1-2) with ks set to ksa or ksi, and fitting the resulting solutions of Equation (5) Tc-Duramycin uptake data in MI ( Figure  3) . The solid lines in Figure 3 demonstrate the ability of the model to fit the data. Table 1 shows the estimated values of the model parameters and measures of precision of these estimates, namely asymptotic 95% confidence intervals.
DISCUSSION
Significant findings from the current investigation include the follows: i) 99m Tc-Duramycin has rapid uptake in the target tissue, presumably in a PE-dependent manner. Once bound, there is minimal washout over extended period of time.
ii) The binding kinetics of 99m TcDuramycin is quantitatively analyzed, where these values allow an indepth understanding of the strength and limitations of this imaging agent. An added benefit is that the availability of quantitative kinetic data enables an assessment of incremental values and for guiding the development of future generation agents. The current findings are discussed in more details as follows.
Cognate interactions between the probe and binding target are dependent on the accessibility of these targets to probe from the vascular region. Smaller probes tend to have a greater tissue been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier. 14 permeability, which leads to a more efficient target access. In terms of total binding capacity (Bmax), this is a parameter that is intrinsic to the target tissue, and is a measure of the available binding sites for a given probe. By comparing the kinetics between Tc-C2A-GST, two membrane-binding agents that differ from structural properties to binding targets, it provides a unique opportunity to look at the total binding capacity from two independent angles. According to the kinetic analysis results, the Bmax Nuclear Medicine and Biology, Vol. 39, No. 6 (August 2012): pg. 821-825. DOI. This article is © Elsevier and permission has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.
(nmol/g) for 99m
Tc-Duramycin, which is the density of available PE, is about 3-fold greater than that of 99m Tc-C2A-GST (Table 2) , which is the density of available PS [13] . This outcome is consistent with the published values of PE/PS ratio from cellular membranes [14] . It is indicative that the molecular targets, PE and PS, are constituents of a single pool of membrane phospholipids exposed in dead and dying cells. A significant point of the current study, therefore, is that the underlying pathophysiology is a constant beyond the variability of different imaging agents or their targets.
The ~3-fold difference in the number of available binding sites for Tc-C2A-GST [13] . This result is in part due to the faster blood clearance rate of 99m Tc-C2A-GST as compared to 99m Tc-C2A-GST (Table 2 ). This stresses the importance of the above kinetic modeling approach for the quantitative interpretation of 99m TcDuramycin kinetic data since the 3-fold difference in the number of available binding sites cannot be predicted directly from the kinetic data without accounting for the contributions of the other factors that determine the uptake kinetics of 99m Tc-Duramycin in MI, including blood clearance rate, probe tissue permeability, and probe-target binding rate constant.
In terms of potential impact on patient care, current clinical radiotracers are valuable in providing perfusion, functional and metabolic information on target tissues, such as the heart; however, there lacks a positive imaging agent for detecting active cell death in degenerative diseases. A targeted radiotracer that binds externalized phospholipids as a surrogate marker for cell death will aid the early detection of tissue injury and the monitoring of the efficacy of therapeutic interventions.
Overall, in a quantitative approach, we have characterized the in vivo behaviors of 99m Tc-Duramycin in the target tissue. The relatively high target-to-background ratio is due to a combination of the following factors: enhanced tissue permeability, site-directed radiolabeling, prompt blood clearance, and a greater target density.
Footnotes
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